DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Share Price Live Updates: Cipla's Current Market Price

Economic Times 3 hrs ago·11 Sept 2026, 2:46 am

Cipla's share price is currently live on the exchange, reflecting the real-time market value of the company's stock. This live tracking allows investors to monitor price movements throughout the trading day, which are influenced by various market factors and the company's performance.

For investors, watching a stock's live price is essential for making timely decisions. It provides a snapshot of how the market perceives Cipla's current standing and can signal shifts in investor sentiment or broader market trends affecting the pharmaceutical sector.

Moving forward, investors should focus on the volume of trades and any major announcements from the company. These elements often provide context to the price changes and help determine the stock's short-term direction.